Range
435.78 - 444.44
Vol / Avg.
174.3K/256.3K
Div / Yield
1.28/0.29%
52 Wk
228.67 - 444.83
Mkt Cap
17.3B
Payout Ratio
27.83
Open
438.22
P/E
96.51
EPS
1.18
Shares
38.9M
Outstanding
38.9M
Total Float
-
Benzinga - 6 days ago
Benzinga - May 19, 2021, 7:13AM
Benzinga - May 18, 2021, 7:04AM
Benzinga - May 10, 2021, 7:12AM
Benzinga - May 6, 2021, 6:37AM
Benzinga - Apr 27, 2021, 7:06AM
Benzinga - Apr 8, 2021, 7:02AM
Benzinga - Mar 29, 2021, 7:07AM
Benzinga - Mar 23, 2021, 7:13AM
Benzinga - Mar 8, 2021, 10:01AM
Benzinga - Mar 8, 2021, 9:53AM
Benzinga - Mar 8, 2021, 7:08AM
Benzinga - Mar 4, 2021, 6:37AM
Benzinga - Mar 3, 2021, 4:47PM
Benzinga - Mar 1, 2021, 7:12AM
Benzinga - Feb 25, 2021, 7:52AM
Benzinga - Feb 23, 2021, 7:04AM
Benzinga - Feb 23, 2021, 6:02AM
load more
Sector: Health Care.Industry: Life Sciences Tools & Services
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells a variety of antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers, and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-03
REV
Q3 2021Est.ActualSurprise
EPS1.5501.790 0.2400
REV228.220M243.552M15.332M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
TECHBio-Techne1.87%17.3B

Bio-Techne Frequently Asked Questions

Q

How do I buy Bio-Techne (TECH) stock?

A

You can purchase shares of Bio-Techne (NASDAQ: TECH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Bio-Techne's (TECH) competitors?

A

Other companies in Bio-Techne’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), PPD (NASDAQ:PPD) and Syneos Health (NASDAQ:SYNH).

Q

What is the target price for Bio-Techne (TECH) stock?

A

The latest price target for Bio-Techne (NASDAQ: TECH) was reported by Stephens & Co. on March 8, 2021. The analyst firm set a price target for 425.00 expecting TECH to fall to within 12 months (a possible -4.27% downside). 10 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Bio-Techne (TECH)?

A

The stock price for Bio-Techne (NASDAQ: TECH) is $443.94 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Bio-Techne (TECH) pay a dividend?

A

There are no upcoming dividends for Bio-Techne. The last dividend paid out to investors was $0.00 on May 14, 2021.

Q

When is Bio-Techne (NASDAQ:TECH) reporting earnings?

A
Bio-Techne’s Q4 earnings are confirmed for after-market on August 3, 2021.
Q

Is Bio-Techne (TECH) going to split?

A

There is no upcoming split for Bio-Techne.

Q

What sector and industry does Bio-Techne (TECH) operate in?

A

Bio-Techne is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.